- Home
- RLMD vs TEI Comparison
RLMD vs TEI Comparison
Compare RLMD & TEI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLMD
- TEI
- Stock Information
- Founded
- RLMD 2004
- TEI 1993
- Country
- RLMD United States
- TEI United States
- Employees
- RLMD N/A
- TEI N/A
- Industry
- RLMD Biotechnology: Pharmaceutical Preparations
- TEI Finance Companies
- Sector
- RLMD Health Care
- TEI Finance
- Exchange
- RLMD Nasdaq
- TEI Nasdaq
- Market Cap
- RLMD 289.7M
- TEI 282.9M
- IPO Year
- RLMD N/A
- TEI N/A
- Fundamental
- Price
- RLMD $3.98
- TEI $6.39
- Analyst Decision
- RLMD Hold
- TEI
- Analyst Count
- RLMD 2
- TEI 0
- Target Price
- RLMD $1.00
- TEI N/A
- AVG Volume (30 Days)
- RLMD 1.8M
- TEI 142.4K
- Earning Date
- RLMD 11-13-2025
- TEI 01-01-0001
- Dividend Yield
- RLMD N/A
- TEI 10.51%
- EPS Growth
- RLMD N/A
- TEI N/A
- EPS
- RLMD N/A
- TEI N/A
- Revenue
- RLMD N/A
- TEI N/A
- Revenue This Year
- RLMD N/A
- TEI N/A
- Revenue Next Year
- RLMD N/A
- TEI N/A
- P/E Ratio
- RLMD N/A
- TEI N/A
- Revenue Growth
- RLMD N/A
- TEI N/A
- 52 Week Low
- RLMD $0.24
- TEI $4.35
- 52 Week High
- RLMD $4.34
- TEI $5.39
- Technical
- Relative Strength Index (RSI)
- RLMD 78.00
- TEI 54.05
- Support Level
- RLMD $2.42
- TEI $6.39
- Resistance Level
- RLMD $2.86
- TEI $6.50
- Average True Range (ATR)
- RLMD 0.43
- TEI 0.07
- MACD
- RLMD 0.15
- TEI -0.00
- Stochastic Oscillator
- RLMD 82.19
- TEI 50.00
About RLMD Relmada Therapeutics Inc.
Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its key product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.
About TEI Templeton Emerging Markets Income Fund Inc.
Templeton Emerging Markets Income Fund is a closed-end fund. It seeks high, current income, with a secondary goal of capital appreciation, by investing, under normal market conditions. The company's investment portfolio includes Foreign Government and Agency Securities; Quasi-Sovereign and Corporate Bonds; Common Stocks and Other Equity Interests, and Short-Term Investments, and Money Market Funds.